Aptevo Therapeutics Inc.
APVO | NASDAQ
$1.84
$0 (0.00%)
At close: Sep 21, 2026, 3:59 PM ET
$1.88
+$0.04 (+2.28%)
Pre-market:
Sep 22, 2026, 4:14 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -6.36M | -6.7M | -5.81M | -7.55M | -6.2M | -6.41M | -6.31M | -5.1M | -5.88M | -6.83M | -5.9M | -6.33M | -7.95M | 2.77M | -4.64M | -7.64M | 28.01M | -7.7M | -6.6M | -7.08M | -7.93M | -7.26M |
Depreciation & Amortization | 32K | 35K | 81K | 49K | 49K | 61K | 71K | 84K | 91K | 106K | 116K | 123K | 150K | 178K | 161K | 222K | 276K | 242K | 260K | 296K | 299K | 294K |
Stock-Based Compensation | 58K | 57K | 2K | 77K | -163K | 180K | -72K | 149K | 273K | 719K | 358K | 455K | 465K | 915K | 357K | 359K | 485K | 601K | 178K | 319K | 572K | 574K |
Other Working Capital | 283K | -1.64M | -1.04M | 11K | 1.09M | -959K | 230K | -818K | 245K | 284K | -213K | -409K | 1.42M | 909K | -328K | -667K | 2.07M | 298K | 487K | -1.36M | 682K | 749K |
Other Non-Cash Items | 257K | 271K | 1.09M | n/a | -273K | 273K | n/a | n/a | n/a | n/a | n/a | 778K | n/a | 10K | 24K | -28K | -35.58M | 1.69M | 2.76M | 2.43M | 2.06M | 297K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -778K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 555K | -1.63M | -602K | 735K | -502K | -681K | 554K | -354K | -634K | -642K | 176K | -485K | 2.53M | 690K | -1.84M | 195K | 3.74M | 50K | -301K | -892K | -49K | -1.41M |
Operating Cash Flow | -5.45M | -7.97M | -5.24M | -6.69M | -7.09M | -6.58M | -5.76M | -5.22M | -6.15M | -6.65M | -5.25M | -6.24M | -4.8M | 4.57M | -5.94M | -6.9M | -3.07M | -5.12M | -3.88M | -5.24M | -5.05M | -7.5M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4K | -25K | n/a | -118K | -13K | -391K | -191K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4K | -25K | n/a | -118K | -13K | -391K | -191K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.47M | -500K | -500K | -500K | -10.77M | 30.8M | -16.08M | n/a | -10.55M |
Common Stock Repurchased | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1K | -1K | 557K | n/a | n/a | n/a | 5.56M | n/a | -1K | -3K | -100K | 3.15M | n/a | -8K | n/a | n/a | -3.11M | 5.83M | -33.9M | 12.97M | 8.32M | 34.49M |
Financial Cash Flow | 726K | 871K | 5.79M | 18.34M | 14.36M | n/a | 6.72M | 4.91M | 3.97M | -3K | 3.05M | 4.34M | 481K | -1.87M | 6M | -500K | -3.18M | -4.94M | -3.08M | -3.02M | 8.32M | 23.94M |
Net Cash Flow | -4.73M | -7.09M | 558K | 11.65M | 7.27M | -6.58M | 961K | -313K | -2.18M | -6.65M | -2.21M | -1.9M | -4.32M | 2.69M | 59K | -7.4M | -6.27M | -10.05M | -7.07M | -8.28M | 2.87M | 16.25M |
Free Cash Flow | -5.45M | -7.97M | -5.24M | -6.69M | -7.09M | -6.58M | -5.76M | -5.22M | -6.15M | -6.65M | -5.25M | -6.24M | -4.8M | 4.57M | -5.94M | -6.9M | -3.1M | -5.12M | -4M | -5.26M | -5.44M | -7.7M |
Adj. Free Cash Flow | -5.51M | -8.02M | -5.24M | -6.77M | -6.93M | -6.76M | -5.69M | -5.37M | -6.43M | -7.37M | -5.61M | -6.7M | -5.27M | 3.65M | -6.3M | -7.26M | -3.58M | -5.72M | -4.18M | -5.57M | -6.02M | -8.27M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4K | -25K | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -118K | -13K | -391K | -191K |
Owner Earnings | -5.45M | -7.97M | -5.24M | -6.69M | -7.09M | -6.58M | -5.76M | -5.22M | -6.15M | -6.65M | -5.25M | -6.24M | -4.8M | 4.57M | -5.94M | -6.9M | -3.1M | -5.12M | -3.88M | -5.24M | -5.05M | -7.5M |
Add to Watchlist
Select watchlists to add or remove APVO